Amylase test: what it measures, normal levels, and what high or low amylase means

Amylase is a digestive enzyme. Salivary glands release one form (the S-type) into the mouth to start breaking down starch, and the pancreas releases another (the P-type) into the small intestine to finish the job. Both glands constantly leak a little enzyme into the bloodstream, and the kidneys clear it, so the level in blood reflects a steady balance between production and clearance. In a healthy adult roughly half or more of the circulating amylase is the salivary type.

When either gland is inflamed, injured or blocked, far more enzyme spills into the blood and the level rises. The classic example is acute pancreatitis: amylase begins climbing within about six to twelve hours of the onset of pain, peaks within the first day or two, and returns to normal in three to five days as the kidneys clear it. That short window is one of the test's weaknesses, because a patient who arrives a few days into an attack can already have a normal amylase.

The serum test measures total amylase in units per liter (U/L). Laboratories can separate the pancreatic and salivary fractions when the source is unclear, and a urine amylase or an amylase-to-creatinine clearance ratio is occasionally added to distinguish a kidney-clearance problem or a benign condition called macroamylasemia from true pancreatic disease.

Sudden, severe pain in the upper abdomen that bores through to the back, especially with nausea and vomiting, is the situation amylase was designed for, and it is an emergency-department test, not one to order online and wait for. Acute pancreatitis is diagnosed when two of three criteria are present: that characteristic pain, amylase or lipase at least three times the upper limit of normal, and typical findings on imaging. Anyone with that pain should be seen the same day.

Outside the emergency setting, amylase is a reasonable check for people at higher risk of pancreatic trouble who have milder or recurrent symptoms: heavy alcohol use, gallstones, very high triglycerides, a previous episode of pancreatitis, a family history of pancreatic disease, or medications known to irritate the pancreas. It is used to follow a known attack back to baseline and, together with lipase, to screen for a salivary or pancreatic source when a routine panel shows an unexplained abnormality.

Two groups ask about it often. People on GLP-1 medicines such as semaglutide and tirzepatide sometimes see mildly raised pancreatic enzymes on routine labs; the drug labels and the American Diabetes Association do not recommend routine enzyme monitoring in the absence of symptoms, because small elevations are common and do not predict pancreatitis, but persistent upper-abdominal pain on these drugs warrants testing. And people with recurrent salivary gland swelling, mumps, or an eating disorder with purging can have a raised amylase that is entirely salivary in origin.

Amylase is a standard blood test available on its own, paired with lipase, or inside a pancreatic function panel. You can have it ordered by your doctor, or order it online from TestWell and walk into a Quest or Labcorp patient service center, with a licensed physician reviewing the order and results in your portal within a few business days. For anything beyond a routine or follow-up check, order lipase with it; the pattern across the two enzymes is what makes the result useful.

Fasting is not strictly required for amylase, but labs often ask for an eight-hour fast when lipase is drawn at the same time, so plan on a morning draw with water only. Avoid alcohol for at least 24 hours, since it can raise both enzymes on its own. Tell the ordering physician about opioid pain medicines, some diuretics, oral contraceptives, valproate and other drugs that can lift amylase, and about any recent salivary gland swelling, abdominal procedure or imaging with contrast.

If the result is unexpectedly high with no symptoms, the usual next move is to repeat it with lipase and a kidney function check rather than to act on a single value. A urine amylase is sometimes added at that point to look for macroamylasemia, in which the enzyme forms large complexes that the kidneys cannot filter; blood amylase stays high, urine amylase is low, and nothing is wrong with the pancreas.

Most laboratories report a normal serum amylase of roughly 26 to 102 U/L for adults, with the exact range depending on the method; your report shows the range for the lab that ran the sample. Children under about a year run lower, because the pancreas does not make its full complement of enzyme until later in infancy, and levels drift down slightly in older adults.

The magnitude of an elevation matters more than the fact of one. Values up to two or three times the upper limit are common and non-specific: kidney disease, bowel disease, medications, a salivary source and macroamylasemia all live in that band. The diagnostic threshold for acute pancreatitis is at least three times the upper limit of normal, and even then the diagnosis rests on the pain and imaging as well. Above that threshold, how high the number goes says little about how severe the attack is; a lipase of five times normal and one of twenty times normal can accompany identical illnesses.

A normal amylase does not rule pancreatitis out. Amylase falls back to normal within days of an attack, it can be normal in pancreatitis caused by very high triglycerides (the fat interferes with the assay), and people with long-standing alcohol-related damage may have too little functioning pancreas left to mount a rise. Lipase, which stays elevated for a week or two and is more specific to the pancreas, is the enzyme guidelines now prefer for the diagnosis.

The causes fall into three groups. Pancreatic causes are acute pancreatitis (gallstones and alcohol account for most cases, followed by high triglycerides, medications and procedures such as ERCP), a flare of chronic pancreatitis, a pancreatic pseudocyst, a blocked pancreatic duct and, less commonly, pancreatic cancer. Salivary causes are mumps and other parotitis, salivary stones, radiation to the head and neck, and chronic vomiting or purging. And there is a set of conditions that raise amylase without involving either gland: reduced kidney clearance in kidney disease, macroamylasemia, and abdominal emergencies such as a perforated ulcer, bowel obstruction, ischemic bowel, cholecystitis, ectopic pregnancy or ovarian cyst rupture, in which enzyme is absorbed across an injured peritoneum.

Diabetic ketoacidosis, alcohol intoxication, some tumors of the lung and ovary that secrete salivary-type amylase, and a long list of medications (opioids are the classic example, because they tighten the sphincter where the pancreatic duct empties) round out the list. Severe head injury, burns and shock can also produce transient elevations.

Sorting these out is what lipase and the clinical picture are for. A high amylase with a normal lipase points away from the pancreas toward a salivary source, macroamylasemia or one of the abdominal or gynecologic causes; a high amylase with a high lipase and the right pain points to the pancreas; a mild elevation of both with an abnormal creatinine usually means the kidneys are clearing less. The shared section on amylase and lipase together lays the patterns out.

A low amylase rarely causes symptoms itself and is usually incidental, but it is not meaningless. The main cause is loss of pancreatic tissue: advanced chronic pancreatitis, cystic fibrosis, pancreatic cancer that has replaced much of the gland, or surgical removal of part of the pancreas. When enough enzyme-producing tissue is gone, digestion suffers, and the symptoms that go with it are oily, floating stools, bloating, weight loss and deficiencies of the fat-soluble vitamins.

Advanced liver disease, poorly controlled diabetes and pre-eclampsia in pregnancy can also lower amylase, and some people simply sit at the bottom of the range with a perfectly healthy pancreas. A low serum amylase is not the test for pancreatic exocrine insufficiency; a fecal elastase measurement is, and it is the next step when a low level comes with digestive symptoms.

Amylase and lipase are almost always ordered as a pair, because each covers the other's blind spots. Lipase is made mostly by the pancreas, so it is more specific; it also rises earlier (within four to eight hours of pain) and stays elevated longer (eight to fourteen days), so it catches attacks that amylase has already missed. Amylase adds the salivary picture and, through the urine test, the macroamylasemia check. The revised Atlanta classification accepts either enzyme at three times the upper limit as the laboratory criterion for acute pancreatitis, and the American College of Gastroenterology's 2024 guideline prefers lipase when only one is available.

Neither enzyme tracks severity, and neither should be re-measured daily to judge recovery; the numbers fall on their own timetable regardless of how the patient is doing. Trending them is useful only to confirm that a mild, symptom-free elevation has resolved.

A high amylase with severe abdominal pain, fever, a racing pulse or persistent vomiting is a same-day emergency evaluation for pancreatitis, regardless of the exact number. Without symptoms, a mild elevation is repeated in a few weeks with lipase and creatinine; if it persists, a urine amylase or isoenzyme fractionation separates salivary, macroamylase and pancreatic sources, and an abdominal ultrasound or CT looks at the pancreas and gallbladder when the pancreatic fraction is the one that is high. Alcohol intake, triglycerides and medications are reviewed at the same visit, since those are the modifiable causes.

A low amylase with weight loss, oily stools or bloating leads to a fecal elastase test and imaging of the pancreas; an isolated low value in someone who feels well is noted and left alone. As always, the person interpreting the result should know the full medication and supplement list, because a surprising number of amylase elevations turn out to be a drug effect that resolves when the drug is changed.